Financials
Financial year 2025
CARDIORYTHM from Ottignies-Louvain-la-Neuve, company number BE0479084087, closed financial year 2025 with a result of € 41,794 after tax. For that financial year CARDIORYTHM recorded a gross margin of € 83,010 and equity of € 165,633. Compared with financial year 2024, the result moved from € 54,026 to € 41,794. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 10, 2026.
€ 165,633
▲ 11% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 41,794
▼ 23% vs 2024
Profit after tax over the fiscal year.
€ 34,026
▼ 10% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 26,000 paid out
62 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 4,074
▼ 67% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 122,690
▼ 7% vs 2024
€ 7,664 is repaid this year. At this pace the long-term loan is gone in ≈ 16 years.
€ 13,202
▼ 14% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 16,544
▼ 34% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 36,636 | € 59,206 | € 103,027 | € 83,010 | ▼ 19% |
| Profit after taxes | € 15,586 | € -1,268 | € 54,026 | € 41,794 | ▼ 23% |
| Equity | € 210,581 | € 150,813 | € 149,839 | € 165,633 | ▲ 11% |
| Total debts | € 33,206 | € 267,269 | € 231,212 | € 178,625 | ▼ 23% |
| Cash | € 47,039 | € 46,874 | € 37,957 | € 34,026 | ▼ 10% |
| Land & buildings | € 48,439 | € 238,557 | € 239,652 | € 231,005 | ▼ 4% |
| Retained profit | € 191,581 | € 131,813 | € 130,839 | € 146,633 | ▲ 12% |
| Dividend | € 0 | € 58,500 | € 55,000 | € 26,000 | ▼ 53% |
| Bank debt | € 15,879 | € 145,996 | € 131,836 | € 122,690 | ▼ 7% |
| Balance sheet total | € 243,787 | € 418,082 | € 381,051 | € 344,259 | ▼ 10% |
Key figures of CARDIORYTHM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about CARDIORYTHM the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to CARDIORYTHM?
What happened at CARDIORYTHM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 41,794 (▼ 23% vs 2024). Source: NBB ↗
- Start of the company according to the CBE. KBO
In short
From € 15,586 profit in 2022 to € 41,794 profit in 2025.
Paid € 55,639 in corporate taxes since 2022.
Best year ever: 2024, with € 54,026 profit.
Paid out € 139,500 in dividends to the owners in total.
Management
Behind CARDIORYTHM are Carine ROCH and Stéphan CHEVALIER.
Directors
According to the 2025 annual accounts
Carine ROCH
Director
Stéphan CHEVALIER
Director
Establishments
Establishment units
Physical locations of this company
Place des Peintres 1 box 203
1348 Ottignies-Louvain-la-Neuve
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0479.084.087
- VAT number
- BE 0479.084.087
- Registered office
- Place des Peintres 1 bus 203, 1348 Ottignies-Louvain-la-Neuve
- Names & denominations
- CARDIORYTHM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 19 December 2002
- Peppol
- Active · Active since 18 Nov 2024